Guggenheim Macro Opportunities Fund returned 2.08% in Q3, outperforming its benchmark, the ICE Bank of America 3-Month U.S.
Q3 2025 Earnings Call Transcript November 13, 2025 Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS ...
And good afternoon, and welcome everyone to the Relmada Therapeutics, Inc. Third Quarter 2025 Conference Call. 2025 is ...
Detailed price information for Autolus Therapeutics Plc ADR (AUTL-Q) from The Globe and Mail including charting and trades.
Detailed price information for Caribou Biosciences Inc (CRBU-Q) from The Globe and Mail including charting and trades.
Gupta-Rawal, S. and Ahsan, M. (2025) The Financial Divide in Football: Exploring the Impact of Financial Inequality on Competitive Balance and Team Performance in European Leagues. Open Journal of ...
VANCOUVER, BC, Nov. 14, 2025 /CNW/ - Eastern Platinum Limited (TSX: ELR) (JSE: EPS) ("Eastplats" or the "Company") is pleased to report that it ...
Kyverna Therapeutics (KYTX) is rated a strong buy with promising KYV-101 Phase 2 data and near-term catalysts. Read here for ...
Positive 9-month follow-up data for NDV-01 showed a 92% overall response rate at any time in non-muscle invasive bladder cancer (NMIBC), with favorable overall safety ...
This common tool that you use every day can facilitate student collaboration and engagement in learning.
HONG KONG, CHINA / ACCESS Newswire / November 14, 2025 / SouthGobi Resources Ltd. (Hong Kong Stock Exchange ("HKEX"):1878, TSX Venture Exchange ("TSX-V"):SGQ) (the "Company" or "SouthGobi") today ...
The old “store and forget” model doesn’t work anymore. Think of data as capital, it's dynamic, and so is the technology that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback